Clinical Trial Update: Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating efficacy and safety of PC-SOD for injection in reducing myocardial reperfusion injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Reperfusion Injury

Drugs mentioned

• PC-SOD for Injection (PC-SOD for Injection)

Snippet

Sponsor: Beijing Tide Pharmaceutical Co., Ltd | Conditions: Myocardial Reperfusion Injury | Phase 2 | Status: UNKNOWN